Corient Private Wealth’s Linde LIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327M Sell
629,501
-67,303
-10% -$34.1M 0.45% 41
2026
Q1
$338M Sell
696,804
-28,997
-4% -$13.7M 0.48% 37
2025
Q4
$310M Buy
725,801
+96,837
+15% +$41.5M 0.42% 44
2025
Q3
$298M Sell
628,964
-68,560
-10% -$32.5M 0.47% 37
2025
Q2
$327M Buy
697,524
+64,047
+10% +$29.2M 0.44% 41
2025
Q1
$295M Buy
633,477
+122,224
+24% +$55M 0.48% 38
2024
Q4
$213M Buy
511,253
+2,132
+0.4% +$972K 0.35% 56
2024
Q3
$243M Sell
509,121
-30,039
-6% -$13.7M 0.38% 51
2024
Q2
$237M Sell
539,160
-3,605
-0.7% -$1.59M 0.41% 49
2024
Q1
$251M Buy
542,765
+4,627
+0.9% +$2M 0.45% 45
2023
Q4
$221M Buy
538,138
+28,150
+6% +$11.1M 0.41% 49
2023
Q3
$190M Sell
509,988
-5,981
-1% -$2.28M 0.44% 48
2023
Q2
$197M Buy
515,969
+91,643
+22% +$33.5M 0.45% 47
2023
Q1
$151M Buy
424,326
+221,082
+109% +$74M 0.41% 59
2022
Q4
$66.3M Buy
+203,244
New +$63.7M 0.24% 108

Other funds holding LIN

Corient Private Wealth's LIN Position: Q2 2026 in Review

Corient Private Wealth reduced its Linde (LIN) stake by 9.7% in Q2 2026, selling an estimated $34.1M and leaving 629,501 shares worth $327M. The position accounts for 0.45% of the portfolio, ranked #41.

Corient Private Wealth first reported a position in LIN in Q4 2022 and has held it in 15 quarters since. The position peaked at $338M in Q1 2026. 2,342 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Corient Private Wealth held 629,501 shares of Linde worth $327M as of Q2 2026.
  • Corient Private Wealth sold 67,303 Linde shares in Q2 2026, an estimated $34.1M.
  • Linde made up 0.45% of Corient Private Wealth's portfolio in Q2 2026, its #41 holding.
  • Corient Private Wealth first reported a position in Linde in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Linde position peaked at $338M in Q1 2026.
  • 2,342 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.